Turner & Townsend appointed to GSK capital portfolio
Professional services business Turner & Townsend has been selected to support GlaxoSmithKline (GSK) with their capital portfolio management in Montrose.
As part of Turner & Townsend’s growing capability across their Real Estate team in Scotland, the appointment includes complete portfolio management of GSK’s key manufacturing facilities in Montrose.
The global property consultancy will provide concept/feasibility project management, as well as project controls (cost and planning) for the portfolio.
As a global supplier to GSK, Turner & Townsend is already providing a full range of services including project and programme management, cost management and projects controls services both globally and UK-wide.
Adding to this existing partnership, Turner & Townsend will be increasing their coverage even further to support GSK’s ongoing Capital investment into the Montrose site, to secure longevity of the site and support continuous improvement of their production line and office facilities.
Daniel Boreham, director of life sciences, Turner & Townsend, said: “This appointment strengthens our long-standing relationship with GSK, whilst providing opportunity to venture into a new region and bring some of our global initiatives such as the benchmarking club which brings GSK together with other major pharmaceutical companies to share data and best practice from across the industry to improve project delivery.
“This commission with GSK, combined with our existing wealth of expertise in the life sciences sector both globally and across the UK, puts us in good stead to taking this next step into the Scottish regions, where we have great ambitions for the industry.”